Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

NCT01528137 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class

Stopped Negative data from another trial led to termination of this trial by sponsor.

Conditions

Interventions

Sponsor

Stanford University

Collaborators